1
TITLE: Retreatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin
AUTHORS: Stefan Zeuzem; Ira M Jacobson; Tolga Baykal; Rui T Marinho; Fred Poordad; Marc Bourliere; Mark S Sulkowski; Heiner Wedemeyer; Edward Tam; Paul Desmond; Donald M Jensen; Adrian M Di Bisceglie; Peter Varunok; Tarek Hassanein; Junyuan Y Xiong; Tami Pilot Matias; Barbara DaSilva Tillmann; Lois Larsen; Thomas Podsadecki; Barry Bernstein;
PUBLISHED: 2014, SOURCE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 370, ISSUE: 17
INDEXED IN: Scopus WOS CrossRef
2
TITLE: Time to Viral Suppression is Not Related to Achievement of SVR12 in HCV GT1-infected Patients Treated with ABT-450/r/Ombitasvir and Dasabuvir With or Without Ribavirin
AUTHORS: Mark S Sulkowski; Michael W Fried; Resat Ozaras; Vasily Isakov; David L Wyles; Peter Ferenci; Jordan J Feld; Filipe Calinas; Michael Gschwantler; Martin King; Tolga Baykal; Edward J Gane;
PUBLISHED: 2014, SOURCE: 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases in HEPATOLOGY, VOLUME: 60
INDEXED IN: WOS